Table 1. Correlation of sulfatase 2 (SULF2) expression with the clinicopathological features of the cervical cancer patients.
| Clinicopathological features | N | SULF2 expression | P | |
|---|---|---|---|---|
| Negative | Positive | |||
| Age | 1.000 | |||
| ≥60 | 34 | 14 | 20 | |
| <60 | 45 | 19 | 26 | |
| Pathological type | 0.316 | |||
| Squamous carcinoma | 56 | 21 | 35 | |
| Adenocarcinoma | 23 | 12 | 11 | |
| Clinical stage | 0.005 | |||
| Ib-IIa | 47 | 26 | 21 | |
| IIb-IIIa | 32 | 7 | 25 | |
| Lymph node metastasis | 0.001 | |||
| With | 34 | 7 | 27 | |
| Without | 45 | 26 | 19 | |
| Differentiation | <0.001 | |||
| Poor differentiation | 22 | 2 | 20 | |
| Moderate/high differentiation | 57 | 31 | 26 | |
| HPV | 0.799 | |||
| Positive | 58 | 25 | 33 | |
| Negative | 21 | 8 | 13 | |
Chi-squared test was used for statistical analysis.